AKAN
Akanda Corp
NASDAQ: AKAN · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$25.99
+48.60% today
Updated 2026-04-29
Market cap
$13.89M
P/E ratio
0.04
P/S ratio
16.60x
EPS (TTM)
$696.80
Dividend yield
—
52W range
$2 – $121
Volume
2.1M
Akanda Corp (AKAN) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-266.30%
Operating margin
-443.80%
ROE
-60.90%
ROA
-28.70%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $0.00 | $-1.89M | — | — | — |
| 2020 | $2062.00 | $-2.30M | 12.27% | -80,787.34% | -111,569.88% |
| 2021 | $41431.00 | $-8.13M | -1,725.10% | -6,203.45% | -19,625.88% |
| 2022 | $2.62M | $-11.66M | 124.81% | -770.18% | -445.00% |
| 2023 | $2.16M | $-32.28M | 5.16% | -465.33% | -1,494.18% |
| 2024 | $836664.00 | $-4.10M | 24.91% | -523.80% | -489.57% |